Satellos Bioscience Inc Com V.ICO

RE:RE:IMNP's 2017 Financial Results

[SuperMoney]

Agree. IMNP prospectus becomes much better now.

Please take a look at IMNP’s annual report at:

https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=12165378&type=HTML&symbol=IMNP&companyName=Immune+Pharmaceuticals+Inc.&formType=10-K&dateFiled=2018-04-02

The following is a quote from this report:

“In December 2010, iCo Therapeutics Inc. (“iCo”) granted Immune an option to sub-license the use and development of bertilimumab for all human indications, other than ocular indications, pursuant to a Product Sublicense Agreement. iCo obtained exclusive license rights to intellectual property relating to bertilimumab pursuant to a license agreement with Cambridge Antibody Technology Group Plc dated December 20, 2006, and to which we became a party. On June 24, 2011, we exercised our option and obtained a worldwide license from iCo pursuant to the Product Sublicense Agreement. We paid iCo $0.5 million and issued to iCo common stock and warrants to purchase our common stock.  iCo is entitled to $32.0 million in milestone payments plus royalties on future development and sales of bertilimumab. Milestones include the first dosing in a phase 3 clinical trial, filing a Biologics License Application/Marketing Authorization Application (“BLA/MMA”) and approval of a BLA/MAA in any indication and the achievement of $100 million in aggregate sales of licensed products for use in IBD. ...”

Obviously, any news/updates from the company could become a strong driver for the next market movement. Personally, I am confident on this given ICO’s good pipelines.

Good luck to everyone!

Please be noted that this is only my opinion. It is NOT any investment advice. Do your own DD.

juansito wrote:
imnp prospectus looks better than year ago...
why Ico price not moving?
everyone waiting for NR...
no April trade yet...
3,5 cents looks a good entry point...at least better than mine...
this play can go up 100% or down to 0 in no time...
GLTA